Many articles have described a negative association between maspin expression and carcinoma progression in several malignancies, including those of the breast, prostate, colon, bladder, thyroid and stomach cancers, lung and oral cavity squamous cell carcinoma, and some renal neoplasms [13,19-22]. This evidence concerns the gene SERPINB5 and gastric neoplasm.